Mark Savill, PhD

Title(s)Assistant Researcher, Psychiatry
SchoolSchool of Medicine
Address401 Parnassus Ave.
San Francisco CA 94143
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Replication of Associations With Psychotic-Like Experiences in Middle Childhood From the Adolescent Brain Cognitive Development (ABCD) Study. Schizophr Bull Open. 2020 Jan; 1(1):sgaa009. Karcher NR, Loewy RL, Savill M, Avenevoli S, Huber RS, Simon TJ, Leckliter IN, Sher KJ, Barch DM. PMID: 32803159.
      View in: PubMed   Mentions:
    2. Psychosis screening in schools: Considerations and implementation strategies. Early Interv Psychiatry. 2020 02; 14(1):130-136. Meyer MS, Rosenthal A, Bolden KA, Loewy RL, Savill M, Shim R, Rodriguez J, Flores V, Pavao E, Niendam TA. PMID: 31287611.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    3. How Do Early Psychosis Services Define and Operationalize the Duration of Untreated Psychosis? J Behav Health Serv Res. 2019 07; 46(3):497-508. Savill M, Gosdin M, Patel P, Melnikow J, Loewy R, Niendam T. PMID: 30298441.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. 7.1 PREDICTORS OF DISTRESSING PSYCHOTIC-LIKE EXPERIENCES IN SCHOOL-AGE CHILDREN. Schizophrenia Bulletin. 2019 Apr 9; 45(Supplement_2):s97-s98. Nicole Karcher, Rachel Loewy, Mark Savill, Kathleen O’Brien, Rebekah Huber, Tony Simon, Ingrid Leckliter, Kenneth Sher, Deanna Barch. .
      View in: Publisher Site   Mentions:
    5. The Rise of Early Psychosis Care in California: An Overview of Community and University-Based Services. Psychiatr Serv. 2019 06 01; 70(6):480-487. Niendam TA, Sardo A, Savill M, Patel P, Xing G, Loewy RL, Dewa CS, Melnikow J. PMID: 30890048.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Assessment of the Prodromal Questionnaire-Brief Child Version for Measurement of Self-reported Psychoticlike Experiences in Childhood. JAMA Psychiatry. 2018 08 01; 75(8):853-861. Karcher NR, Barch DM, Avenevoli S, Savill M, Huber RS, Simon TJ, Leckliter IN, Sher KJ, Loewy RL. PMID: 29874361.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    7. Which components of specialized early intervention for psychosis do senior providers see as most important? Early Interv Psychiatry. 2019 06; 13(3):677-681. Savill M, Sardo A, Patel P, Loewy R, Melnikow J, Niendam T. PMID: 29882258.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Acceptability of Psychosis Screening and Factors Affecting Its Implementation: Interviews With Community Health Care Providers. Psychiatr Serv. 2018 06 01; 69(6):689-695. Savill M, Skymba HV, Ragland JD, Niendam T, Loewy RL, Lesh TA, Carter C, Goldman HH. PMID: 29606073.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. 4.2 A TECHNOLOGY-ENHANCED INTERVENTION TO REDUCE THE DURATION OF UNTREATED PSYCHOSIS THROUGH RAPID IDENTIFICATION & ENGAGEMENT. Schizophrenia Bulletin. 2018 Apr 1; 44(Suppl 1):s4-s4. Tara Niendam, Rachel Loewy, Mark Savill, Monet Meyer, Adi Rosenthal, Kevin Delucchi, Tyler Lesh, Haley Skymba, J Daniel Ragland, Howard Goldman, Rosemary Cress, Richard Kravitz, Cameron Carter. .
      View in: Publisher Site   Mentions:
    10. Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review. Early Interv Psychiatry. 2018 02; 12(1):3-14. Savill M, D'Ambrosio J, Cannon TD, Loewy RL. PMID: 28782283.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    11. Correspondence between negative symptoms and potential sources of secondary negative symptoms over time. Eur Arch Psychiatry Clin Neurosci. 2018 Sep; 268(6):603-609. Farreny A, Savill M, Priebe S. PMID: 28577223.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. 185. A Technology-Enhanced Intervention to Reduce the Duration of Untreated Psychosis Through Rapid Identification and Engagement. Schizophrenia Bulletin. 2017 Mar 1; 43(suppl_1):s98-s98. Tara Niendam, Rachel Loewy, Daniel Ragland, Tyler Lesh, Haley Skymba, Mark Savill, Katherine Pierce, Taylor Fedechko, Kevin Delucchi, Howard Goldman, Rosemary Cress, Cameron Carter. .
      View in: Publisher Site   Mentions:
    13. M132. Barriers and Facilitators to Implementing a Psychosis Screening Procedure in Different Health Care Settings. Schizophrenia Bulletin. 2017 Mar 1; 43(suppl_1):s258-s259. Mark Savill, Haley Skymba, Tara Niendam, Rachel Loewy, Tyler Lesh, Daniel Ragland, Cameron Carter, Howard Goldman. .
      View in: Publisher Site   Mentions:
    14. The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data. Psychiatry Res. 2017 Jan; 247:73-78. Savill M, Orfanos S, Bentall R, Reininghaus U, Wykes T, Priebe S. PMID: 27871030.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial. Health Technol Assess. 2016 Feb; 20(11):vii-xxiii, 1-100. Priebe S, Savill M, Wykes T, Bentall R, Lauber C, Reininghaus U, McCrone P, Mosweu I, Bremner S, Eldridge S, Röhricht F, NESS team . PMID: 26869182.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Letter to the Editor: Concepts and methods when considering negative symptom course: a reply. Psychol Med. 2015 Aug; 45(11):2459-60. Savill M, Priebe S. PMID: 25919939.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data. Psychol Med. 2015 Jun; 45(8):1613-27. Savill M, Banks C, Khanom H, Priebe S. PMID: 25425086.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    18. A pragmatic randomised controlled trial of dialectical behaviour therapy: effects on hospitalisation and post-treatment follow-up. Psychother Psychosom. 2014; 83(3):192-3. Barnicot K, Savill M, Bhatti N, Priebe S. PMID: 24752222.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia--a multi-centre randomised controlled trial. BMC Psychiatry. 2013 Jan 14; 13:26. Priebe S, Savill M, Reininghaus U, Wykes T, Bentall R, Lauber C, McCrone P, Röhricht F, Eldridge S. PMID: 23317474.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    20. Recovery in Borderline Personality Disorder (BPD): a qualitative study of service users' perspectives. PLoS One. 2012; 7(5):e36517. Katsakou C, Marougka S, Barnicot K, Savill M, White H, Lockwood K, Priebe S. PMID: 22615776.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    21. Symptom levels and initial appraisal of hospital treatment in patients with schizophrenia. Psychiatry Res. 2012 Sep 30; 199(2):79-83. Savill M, Jankovic J, Katsakou C, Kallert T, Priebe S. PMID: 22565214.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Factors predicting the outcome of psychotherapy for borderline personality disorder: a systematic review. Clin Psychol Rev. 2012 Jul; 32(5):400-12. Barnicot K, Katsakou C, Bhatti N, Savill M, Fearns N, Priebe S. PMID: 22681913.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans